Belvedere Trading
VKTX icon

Belvedere Trading’s Viking Therapeutics VKTX Stock Holding History

Belvedere Trading’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,098
Closed -$44.2K – 1011
2024
Q4 		$44.2K Buy
+1,098
New +$62.6K ﹤0.01% 617
2024
Q3 		– Sell
-1,081
Closed -$63.4K – 954
2024
Q2 		$57.3K Sell
1,081
-34,960
-97% -$2.29M ﹤0.01% 497
2024
Q1 		$2.96M Buy
36,041
+19,709
+121% +$877K ﹤0.01% 55
2023
Q4 		$304K Sell
16,332
-4,553
-22% -$59.5K ﹤0.01% 244
2023
Q3 		$231K Sell
20,885
-35,637
-63% -$510K ﹤0.01% 199
2023
Q2 		$916K Buy
56,522
+1,880
+3% +$39.4K ﹤0.01% 83
2023
Q1 		$910K Buy
+54,642
New +$564K ﹤0.01% 80

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return